Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1246037

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential


Vuić, Barbara; Miloš, Tina; Tudor, Lucija; Konjevod, Marcela; Nikolac Perković, Matea; Jazvinšćak Jembrek, Maja; Nedić Erjavec, Gordana; Švob Štrac, Dubravka
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential // Biomedicines, 10 (2022), 12; 3000, 31 doi:10.3390/biomedicines10123000 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1246037 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential

Autori
Vuić, Barbara ; Miloš, Tina ; Tudor, Lucija ; Konjevod, Marcela ; Nikolac Perković, Matea ; Jazvinšćak Jembrek, Maja ; Nedić Erjavec, Gordana ; Švob Štrac, Dubravka

Izvornik
Biomedicines (2227-9059) 10 (2022), 12; 3000, 31

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
neurodegenerative diseases ; proteinopathies ; endocannabinoid system ; cannabinoid CB2 receptors ; neuroinflammation ; therapy

Sažetak
Some of the most prevalent neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease, are proteinopathies characterized by the accumulation of specific protein aggregates in the brain. Such misfolded protein aggregates can trigger modulation of the innate and adaptive immune systems and subsequently lead to chronic neuroinflammation that drives the onset and progression of neurodegenerative diseases. Since there is still no effective disease- modifying treatment, new therapeutic targets for neurodegenerative proteinopathies have been sought. The endocannabinoid system, and in particular the cannabinoid CB2 receptors, have been extensively studied, due to their important role in neuroinflammation, especially in microglial cells. Several studies have shown promising effects of CB2 receptor activation on reducing protein aggregationbased pathology as well as on attenuating inflammation and several dementia- related symptoms. In this review, we discuss the available data on the role of CB2 receptors in neuroinflammation and the potential benefits and limitations of specific agonists of these receptors in the therapy of neurodegenerative proteinopathies.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov www.mdpi.com fulir.irb.hr

Citiraj ovu publikaciju:

Vuić, Barbara; Miloš, Tina; Tudor, Lucija; Konjevod, Marcela; Nikolac Perković, Matea; Jazvinšćak Jembrek, Maja; Nedić Erjavec, Gordana; Švob Štrac, Dubravka
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential // Biomedicines, 10 (2022), 12; 3000, 31 doi:10.3390/biomedicines10123000 (međunarodna recenzija, članak, znanstveni)
Vuić, B., Miloš, T., Tudor, L., Konjevod, M., Nikolac Perković, M., Jazvinšćak Jembrek, M., Nedić Erjavec, G. & Švob Štrac, D. (2022) Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential. Biomedicines, 10 (12), 3000, 31 doi:10.3390/biomedicines10123000.
@article{article, author = {Vui\'{c}, Barbara and Milo\v{s}, Tina and Tudor, Lucija and Konjevod, Marcela and Nikolac Perkovi\'{c}, Matea and Jazvin\v{s}\'{c}ak Jembrek, Maja and Nedi\'{c} Erjavec, Gordana and \v{S}vob \v{S}trac, Dubravka}, year = {2022}, pages = {31}, DOI = {10.3390/biomedicines10123000}, chapter = {3000}, keywords = {neurodegenerative diseases, proteinopathies, endocannabinoid system, cannabinoid CB2 receptors, neuroinflammation, therapy}, journal = {Biomedicines}, doi = {10.3390/biomedicines10123000}, volume = {10}, number = {12}, issn = {2227-9059}, title = {Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential}, keyword = {neurodegenerative diseases, proteinopathies, endocannabinoid system, cannabinoid CB2 receptors, neuroinflammation, therapy}, chapternumber = {3000} }
@article{article, author = {Vui\'{c}, Barbara and Milo\v{s}, Tina and Tudor, Lucija and Konjevod, Marcela and Nikolac Perkovi\'{c}, Matea and Jazvin\v{s}\'{c}ak Jembrek, Maja and Nedi\'{c} Erjavec, Gordana and \v{S}vob \v{S}trac, Dubravka}, year = {2022}, pages = {31}, DOI = {10.3390/biomedicines10123000}, chapter = {3000}, keywords = {neurodegenerative diseases, proteinopathies, endocannabinoid system, cannabinoid CB2 receptors, neuroinflammation, therapy}, journal = {Biomedicines}, doi = {10.3390/biomedicines10123000}, volume = {10}, number = {12}, issn = {2227-9059}, title = {Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential}, keyword = {neurodegenerative diseases, proteinopathies, endocannabinoid system, cannabinoid CB2 receptors, neuroinflammation, therapy}, chapternumber = {3000} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font